Back
AtriCure Vs. Perspective Therapeutics Industry Stock Comparison
Sell
20
ATRC
AtriCure
Last Price:
22.93
Seasonality Move:
14.54%
Buy
89
CATX
Perspective Therapeutics
Last Price:
1.52
Seasonality Move:
10.1%
Sell
20
AtriCure (ATRC)
is a Sell
Is AtriCure a Buy, Sell or Hold?
- The current AtriCure [ATRC] share price is $24.09. The Score for ATRC is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- ATRC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
89
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.47. The Score for CATX is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
ATRC Stock Price Chart
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.47
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ATRC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.11 | Sell |
| Relative Strength Index (14 RSI): | 26.9 | Sell |
| Chaikin Money Flow: | -221808 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.25 - 33.05) | Sell |
| Bollinger Bands (100): | (30.15 - 37.35) | Sell |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 63.46 | Buy |
| Chaikin Money Flow: | 3643786 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.12 - 1.44) | Buy |
| Bollinger Bands (100): | (0.35 - 1.15) | Buy |
ATRC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.03 | Sell |
| 20-day SMA: | 28.33 | Sell |
| 50-day SMA: | 31.88 | Sell |
| 200-day SMA: | 39.36 | Sell |
| 8-day EMA: | 26.14 | Sell |
| 20-day EMA: | 28.25 | Sell |
| 50-day EMA: | 31 | Sell |
| 200-day EMA: | 37.04 | Sell |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.47 | Sell |
| 20-day SMA: | 1.32 | Buy |
| 50-day SMA: | 1.1 | Buy |
| 200-day SMA: | 0.58 | Buy |
| 8-day EMA: | 1.45 | Buy |
| 20-day EMA: | 1.34 | Buy |
| 50-day EMA: | 1.11 | Buy |
| 200-day EMA: | 0.7 | Buy |
AtriCure Earnings Growth & ATRC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.00 per share, and an increase next year of $0.17 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
AtriCure Technical Analysis
| Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||